Comparable stake leader
LIGAND PHARMACEUTICALS INC
SEC ownership of XOMA Royalty Corp
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0000791908.
Disclosed value leader
LIGAND PHARMACEUTICALS INC
Comparable rows
50/50
Latest evidence
27 Apr 2026
- Public ticker
- XOMA, XOMAO, XOMAP on Nasdaq
- Parsed ownership sources
-
13D/G and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
LIGAND PHARMACEUTICALS INC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
LIGAND PHARMACEUTICALS INC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
27 Apr 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0000791908
- Issuer location
- Emeryville, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of XOMA Royalty Corp (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
LIGAND PHARMACEUTICALS INC
Disclosed value leader
LIGAND PHARMACEUTICALS INC
Comparable rows
50/50
Latest evidence
27 Apr 2026
13D/G
13F
Lead comparable stake: 47%
13D/G row: LIGAND PHARMACEUTICALS INC
Showing 1-8 of 50 holder rows.
Quick read
LIGAND PHARMACEUTICALS INC leads the comparable SEC ownership view at 47%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens LIGAND PHARMACEUTICALS INC's linked filing trail.
Comparable ownership
Top 5
LIGAND PHARMACEUTICALS INC
47%
MORGAN STANLEY
14%
FMR LLC
10%
Woodline Partners LP
5.4%
BlackRock, Inc.
5.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| LIGAND PHARMACEUTICALS INC |
13D/G
Ligand Pharmaceuticals Incorporated
|
47%
|
$311,622,505
8,062,678 shares
|
$0 | 27 Apr 2026 |
| MORGAN STANLEY |
13F
13D/G
Company
|
14%
from 13D/G
|
$53,396,665
1,702,157 shares
|
— | 31 Mar 2026 |
| FMR LLC |
13F
13D/G
Company
|
10%
from 13D/G
|
$40,874,300
1,302,974 shares
|
— | 31 Mar 2026 |
| Woodline Partners LP |
13D/G
13F
Company
|
5.4%
|
$24,736,039
640,001 shares
|
$0 | 31 Mar 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
5.4%
from 13D/G
|
$20,293,692
646,914 shares
|
— | 31 Mar 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13D/G
13F
Vanguard Capital Management · Company
|
5.2%
|
$19,244,177
613,458 shares
|
$0 | 31 Mar 2026 |
| BVF INC/IL |
13F
Company
|
15%
|
$81,257,805
2,590,303 shares
|
— | 31 Mar 2026 |
| Opaleye Management Inc. |
13F
Company
|
1.7%
|
$9,411,000
300,000 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to buying over the last 12 months. Net value: +$2,349,180.
Buys
$2,505,000
Insiders: 1
Sells
$155,820
Insiders: 1
Net
+$2,349,180
Shares: +95,670
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 100,000
Shares: 4,330
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 100,000 | 0 | $2,505,000 | $0 | +$2,505,000 |
| 9-12 | 0 | 4,330 | $0 | $155,820 | -$155,820 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 23 reporting-owner rows connected to XOMA Royalty Corp. Open a relationship link for the CIK-to-CIK filing trail.
Rows
23
Largest Forms 3/4/5 holder
BVF PARTNERS L P/IL
Net 12M change
+$2,349,180
Latest report
14 Jul 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| BVF PARTNERS L P/IL | 10%+ Owner | $29,138,240 | Mixed | 14 Jul 2026 | ||
| Owen Hughes | Chief Executive Officer, Director | $5,633,680 | +$2,505,000 | +80% | Mixed | 14 Jul 2026 |
| Thomas M. Burns | SVP, Finance & CFO | $3,626,717 | -$155,820 | -4.1% | Mixed | 19 Sep 2025 |
| Joseph M. Limber | Director | $761,000 | Mixed | 14 Jul 2026 | ||
| James R. Neal | CEO, Director | $636,556 | Mixed | 15 Jul 2022 | ||
| Bradley Sitko | Chief Investment Officer | $386,156 | Mixed | 14 Jul 2026 | ||
| Jeffrey Trigilio | Chief Financial Officer | $0 | Mixed | 14 Jul 2026 | ||
| BVF I GP LLC | 10%+ Owner | $0 | Mixed | 14 Jul 2026 | ||
| BIOTECHNOLOGY VALUE FUND II LP | 10%+ Owner | $0 | Mixed | 14 Jul 2026 | ||
| BVF GP HOLDINGS LLC | 10%+ Owner | $0 | Mixed | 14 Jul 2026 | ||
| BVF INC/IL | 10%+ Owner | $0 | Mixed | 14 Jul 2026 | ||
| BIOTECHNOLOGY VALUE FUND L P | 10%+ Owner | $0 | Mixed | 14 Jul 2026 | ||
| Heather L. Franklin | Director | $0 | Mixed | 14 Jul 2026 | ||
| BVF II GP LLC | 10%+ Owner | $0 | Mixed | 14 Jul 2026 | ||
| Biotechnology Value Trading Fund OS LP | Other* | $0 | Mixed | 14 Jul 2026 | ||
| BVF Partners OS Ltd. | Other* | $0 | Mixed | 14 Jul 2026 | ||
| Mark N. Lampert | 10%+ Owner | $0 | Mixed | 14 Jul 2026 | ||
| Matthew D. Perry | Director | $0 | Mixed | 14 Jul 2026 | ||
| Barbara Kosacz | Director | $0 | Mixed | 14 Jul 2026 | ||
| Natasha Hernday | Director | $0 | Mixed | 14 Jul 2026 |
Recent insider transactions for XOMA Royalty Corp
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| BVF PARTNERS L P/IL | XOMA | Common Stock, $0.0075 par value per share | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -772,000 | 0 | 14 Jul 2026 | See footnote | ||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -772,000 | 0 | 14 Jul 2026 | See footnote | ||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -772,000 | 0 | 14 Jul 2026 | See footnote | ||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -772,000 | 0 | 14 Jul 2026 | See footnote | ||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -772,000 | 0 | 14 Jul 2026 | See footnote | ||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -772,000 | 0 | 14 Jul 2026 | See footnote | ||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -772,000 | 0 | 14 Jul 2026 | See footnote | ||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -772,000 | 0 | 14 Jul 2026 | See footnote | ||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -772,000 | 0 | 14 Jul 2026 | See footnote | ||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -772,000 | 0 | 14 Jul 2026 | See footnote | ||
| BVF PARTNERS L P/IL | XOMA | Common Stock, $0.0075 par value per share | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -6,821,303 | 0 | 14 Jul 2026 | Direct | ||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -6,821,303 | 0 | 14 Jul 2026 | Direct | ||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -6,821,303 | 0 | 14 Jul 2026 | Direct | ||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -6,821,303 | 0 | 14 Jul 2026 | Direct | ||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -6,821,303 | 0 | 14 Jul 2026 | Direct | ||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -6,821,303 | 0 | 14 Jul 2026 | Direct | ||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -6,821,303 | 0 | 14 Jul 2026 | Direct | ||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -6,821,303 | 0 | 14 Jul 2026 | Direct | ||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -6,821,303 | 0 | 14 Jul 2026 | Direct | ||
| Bvf Partners L P/Il | XOMA | Common Stock, $0.0075 par value per share | Disposition pursuant to a tender of shares in a change of control transaction | -100% | -6,821,303 | 0 | 14 Jul 2026 | Direct | ||
| Maricel Perea Montano | XOMA | Common Stock | Other | -100% | -65 | 0 | 14 Jul 2026 | By 401(k) Plan | ||
| Maricel Perea Montano | XOMA | Common Stock | Other | -100% | -42,306 | 0 | 14 Jul 2026 | Direct | ||
| Maricel Perea Montano | XOMA | Performance Stock Units | Disposed to Issuer | -100% | -48,390 | 0 | 14 Jul 2026 | Direct | ||
| Joseph M. Limber | XOMA | Depositary Shares - 8.375% Series B Cumulative Stock | Disposed to Issuer | -100% | -20,000 | 0 | 14 Jul 2026 | Direct | ||
| Joseph M. Limber | XOMA | 8.625% Series A Cumulative Perpetual Preferred Stock | Disposed to Issuer | -100% | -10,000 | 0 | 14 Jul 2026 | Direct | ||
| Joseph M. Limber | XOMA | Common Stock | Other | -100% | -9,532 | 0 | 14 Jul 2026 | Direct | ||
| Joseph M. Limber | XOMA | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -74,500 | 0 | 14 Jul 2026 | Direct | ||
| Barbara Kosacz | XOMA | Common Stock | Other | -100% | -6,269 | 0 | 14 Jul 2026 | Direct | ||
| Barbara Kosacz | XOMA | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -69,125 | 0 | 14 Jul 2026 | Direct | ||
| Jack L. Wyszomierski | XOMA | Common Stock | Other | -100% | -21,828 | 0 | 14 Jul 2026 | Direct | ||
| Jack L. Wyszomierski | XOMA | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -54,801 | 0 | 14 Jul 2026 | Direct | ||
| Owen Hughes | XOMA | Depositary Shares - 8.375% Series B Cumulative Stock | Disposed to Issuer | -100% | -102,000 | 0 | 14 Jul 2026 | Direct | ||
| Owen Hughes | XOMA | Common Stock | Other | -100% | -752 | 0 | 14 Jul 2026 | By 401(k) Plan | ||
| Owen Hughes | XOMA | Common Stock | Other | -100% | -191,264 | 0 | 14 Jul 2026 | Direct | ||
| Owen Hughes | XOMA | Performance Stock Units | Disposed to Issuer | -100% | -248,959 | 0 | 14 Jul 2026 | Direct | ||
| Owen Hughes | XOMA | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -175,000 | 0 | 14 Jul 2026 | Direct | ||
| Natasha Hernday | XOMA | 8.625% Series A Cumulative Perpetual Preferred Stock | Disposed to Issuer | -100% | -4,000 | 0 | 14 Jul 2026 | Direct | ||
| Natasha Hernday | XOMA | Common Stock | Other | -100% | -9,304 | 0 | 14 Jul 2026 | Direct | ||
| Natasha Hernday | XOMA | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -43,196 | 0 | 14 Jul 2026 | Direct | ||
| Bradley Sitko | XOMA | Depositary Shares - 8.375% Series B Cumulative Stock | Disposed to Issuer | -100% | -2,000 | 0 | 14 Jul 2026 | By spouse | ||
| Bradley Sitko | XOMA | 8.625% Series A Cumulative Perpetual Preferred Stock | Disposed to Issuer | -100% | -82 | 0 | 14 Jul 2026 | By spouse | ||
| Bradley Sitko | XOMA | Common Stock | Other | -100% | -1,500 | 0 | 14 Jul 2026 | By spouse | ||
| Bradley Sitko | XOMA | Common Stock | Other | -100% | -75 | 0 | 14 Jul 2026 | By child | ||
| Bradley Sitko | XOMA | Common Stock | Other | -100% | -1,287 | 0 | 14 Jul 2026 | By 401(k) | ||
| Bradley Sitko | XOMA | Depositary Shares - 8.375% Series B Cumulative Stock | Disposed to Issuer | -100% | -7,045 | 0 | 14 Jul 2026 | Direct | ||
| Bradley Sitko | XOMA | 8.625% Series A Cumulative Perpetual Preferred Stock | Disposed to Issuer | -100% | -313 | 0 | 14 Jul 2026 | Direct | ||
| Bradley Sitko | XOMA | Common Stock | Other | -100% | -83,765 | 0 | 14 Jul 2026 | Direct | ||
| Bradley Sitko | XOMA | Performance Stock Units | Disposed to Issuer | -100% | -64,600 | 0 | 14 Jul 2026 | Direct | ||
| Bradley Sitko | XOMA | Stock Option (Right to Buy) | Disposed to Issuer | -100% | -550,000 | 0 | 14 Jul 2026 | Direct | ||
| Matthew D. Perry | XOMA | Common Stock | Other | -100% | -24,138 | 0 | 14 Jul 2026 | Direct |
* marks a reported price that did not pass the local price check.